Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes
- DOI
- 10.1111/dom.12543
- Published
- 2015-09-04
- Container
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/dom.12543,
title = {Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes},
author = {S. Matthaei and K. Bowering and K. Rohwedder and J. Sugg and S. Parikh and E. Johnsson and Unknown},
year = {2015},
journal = {Diabetes, Obesity and Metabolism},
doi = {10.1111/dom.12543},
url = {https://doi.org/10.1111/dom.12543}
}RIS
TY - JOUR TI - Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes AU - S. Matthaei AU - K. Bowering AU - K. Rohwedder AU - J. Sugg AU - S. Parikh AU - E. Johnsson AU - Unknown PY - 2015 JO - Diabetes, Obesity and Metabolism DO - 10.1111/dom.12543 UR - https://doi.org/10.1111/dom.12543 ER -
APA
Matthaei, S., Bowering, K., Rohwedder, K., Sugg, J., Parikh, S., Johnsson, E., & Unknown (2015). Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12543
Source records
- crossref · retrieved 2026-09-26T23:55:32.214Z